US Broker Ratings

Grab Holdings Limited (GRAB): Investor Outlook with a 66.74% Potential Upside

Grab Holdings Limited (NASDAQ: GRAB), the Southeast Asian technology giant, has carved out a significant niche with its extensive superapp ecosystem, offering everything from ride-hailing and food delivery to digital..

aTyr Pharma, Inc. (ATYR) Stock Analysis: Exploring a 372% Upside Potential in the Biotech Sector

aTyr Pharma, Inc. (NASDAQ: ATYR), a clinical-stage biotechnology company, is capturing investor attention with its potential for significant upside. Currently trading at $0.9219, aTyr Pharma offers a striking potential upside..

CytomX Therapeutics, Inc. (CTMX) Stock Analysis: Exploring an 84% Upside Potential in Biotech Innovation

CytomX Therapeutics, Inc. (NASDAQ: CTMX) is an intriguing player in the biotechnology sector, dedicated to advancing oncology-focused therapeutics. With a market capitalization of $826.84 million, the company is leveraging its..

Sprinklr, Inc. (CXM) Stock Analysis: Evaluating a 53% Potential Upside in the Tech Sector

Sprinklr, Inc. (NYSE: CXM), a major player in the technology sector, has been attracting attention due to its robust suite of enterprise cloud software products. Operating in the software application..

NetClass Technology Inc (NTCL) Stock Analysis: A Closer Look at Potential Growth Amidst Challenges

NetClass Technology Inc (NTCL), a Singapore-based technology company operating in the software application industry, presents an intriguing case for investors looking to explore the educational tech sector. Despite its small..

Spok Holdings, Inc. (SPOK) Stock Analysis: Navigating a 10.31% Dividend Yield and 15.42% Upside Potential

Spok Holdings, Inc. (NASDAQ: SPOK), a key player in the healthcare communication solutions sector, presents a compelling case for investors seeking income-generating opportunities. With a market capitalization of $251.46 million,..

SANUWAVE Health, Inc. (SNWV) Stock Analysis: Exploring a Potential 142.91% Upside in the Medical Device Sector

SANUWAVE Health, Inc. (SNWV), a player in the burgeoning healthcare sector, specifically within the medical device industry, is capturing investor attention with a compelling potential upside of 142.91%. As the..

Adobe Inc. (ADBE) Stock Analysis: Exploring a Potential 40% Upside Amidst Tech Sector Volatility

As investors navigate the ever-evolving landscape of the technology sector, Adobe Inc. (NASDAQ: ADBE) presents a compelling opportunity with a notable potential upside of 40.74%. Known for its innovative software..

Alpha Teknova, Inc. (TKNO) Stock Analysis: Exploring a Potential 232% Upside in the Healthcare Sector

Alpha Teknova, Inc. (NASDAQ: TKNO), a key player in the healthcare sector, operates within the niche of drug manufacturers, focusing on specialty and generic products. Based in Hollister, California, Alpha..

AudioEye, Inc. (AEYE) Stock Analysis: Analyst Ratings Signal a 184% Upside Potential

AudioEye, Inc. (NASDAQ: AEYE) presents an intriguing opportunity for investors looking to tap into the burgeoning field of digital accessibility. With a market capitalization of $73.02 million, this Tucson, Arizona-based..

Outset Medical, Inc. (OM) Stock Analysis: Exploring a 222% Potential Upside

Outset Medical, Inc. (NASDAQ: OM), a burgeoning name in the medical devices industry, is capturing investor attention with its innovative approach to hemodialysis and a staggering potential upside of 222.09%...

WeRide Inc. (WRD) Stock Analysis: Exploring a 132% Potential Upside with Strong Buy Ratings

WeRide Inc. (NASDAQ: WRD), a prominent player in the autonomous driving technology sector, is garnering significant attention from investors due to its promising growth potential. Based in Guangzhou, China, WeRide..

CS Disco, Inc. (LAW) Stock Analysis: Exploring the 54% Upside Potential Amid AI-Powered Legal Innovations

CS Disco, Inc. (NYSE: LAW) is making waves in the technology sector with its cutting-edge, cloud-native, and AI-powered legal products. Specializing in software applications for legal hold, ediscovery, and case..

Investor Outlook: NANO-X IMAGING LTD (NNOX) and Its Potential 181% Upside

For investors seeking exposure to the healthcare sector, particularly within the medical devices industry, Nano-X Imaging Ltd. (NASDAQ: NNOX) presents an intriguing opportunity. The Israeli company, with a market capitalization..

Abeona Therapeutics Inc. (ABEO) Investor Outlook: Unpacking a 320% Potential Upside

Abeona Therapeutics Inc. (ABEO), a clinical-stage biopharmaceutical company, is catching the eye of investors with a tantalizing potential upside of 320.59%. With its focus on gene and cell therapies for..

Aura Biosciences, Inc. (AURA) Stock Analysis: Exploring a Potential 256% Upside in Biotechnology

Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company based in Boston, Massachusetts, has captured the attention of the investment community with its innovative approach to treating solid tumors. With..

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: Unveiling an 87.89% Potential Upside with Strong Buy Ratings

Investors eyeing opportunities in the biotechnology sector may want to consider Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL), a company on the forefront of developing therapies for hematologic disorders and cancer. With..

Viant Technology Inc. (DSP) Stock Analysis: Exploring a 56% Potential Upside in the Ad Tech Space

Viant Technology Inc. (NASDAQ: DSP) is generating buzz in the investment community with its compelling market position and growth potential in the rapidly evolving ad tech sector. With a market..

Full Truck Alliance Co. Ltd. (YMM) Stock Analysis: Exploring a 45.81% Upside Potential

Full Truck Alliance Co. Ltd. (NYSE: YMM), a pivotal player in the technology sector, is making waves in the software-application industry with its innovative digital freight platform. As a company..

Gossamer Bio, Inc. (GOSS) Stock Analysis: Exploring a 652% Upside Potential Amidst Clinical Trials

Gossamer Bio, Inc. (NASDAQ: GOSS), a clinical-stage biopharmaceutical company headquartered in San Diego, California, is navigating the challenging but potentially rewarding path of drug development for pulmonary arterial hypertension (PAH)...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds